Association of Zinc Supplementation with Recombinant Protein Recovery and Crystallization

Reproducible production of stable recombinant proteins is essential for biochemical and structural studies, but conventional optimization may be insufficient when constrained by protein-specific requirements.In this study, we investigated batch-to-batch variation in the recombinant production of a putative Zn 2+ -dependent metalloprotease from Cutibacterium acnes.Protein expression and purification yields varied despite identical procedures, and conventional optimization failed to restore consistency.AlphaFold2 modeling and comparison with a Zn 2+ -bound homolog suggested a conserved Zn 2+ -binding site.Protein production was therefore compared between cultures grown with and without Zn 2+ supplementation.The Zn 2+ -supplemented batch exhibited a stronger target-protein band on SDS-PAGE and a larger A 280 peak on size-exclusion chromatography, indicating greater protein recovery.Under identical crystallization conditions, the unsupplemented protein predominantly formed microcrystals of approximately 50 μm, whereas the Zn 2+ -supplemented protein formed larger crystals of approximately 300-500 μm.These findings associate Zn 2+ supplementation with increased protein recovery and larger crystal formation, highlighting the importance of considering protein-specific cofactor requirements during recombinant protein production.

Authors

Institutions

Publication Details

Journal
Drug Targets and Therapeutics
Published
2026-09-28
DOI
https://doi.org/10.58502/dtt.26.0020
Primary Topic
Trace Elements in Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Association of Zinc Supplementation with Recombinant Protein Recovery and Crystallization

Hyo Jung Kim
Drug Targets and Therapeutics
Trace Elements in Health
article

Association of Zinc Supplementation with Recombinant Protein Recovery and Crystallization

Hyo Jung Kim
article en

Abstract

Reproducible production of stable recombinant proteins is essential for biochemical and structural studies, but conventional optimization may be insufficient when constrained by protein-specific requirements.In this study, we investigated batch-to-batch variation in the recombinant production of a putative Zn 2+ -dependent metalloprotease from Cutibacterium acnes.Protein expression and purification yields varied despite identical procedures, and conventional optimization failed to restore consistency.AlphaFold2 modeling and comparison with a Zn 2+ -bound homolog suggested a conserved Zn 2+ -binding site.Protein production was therefore compared between cultures grown with and without Zn 2+ supplementation.The Zn 2+ -supplemented batch exhibited a stronger target-protein band on SDS-PAGE and a larger A 280 peak on size-exclusion chromatography, indicating greater protein recovery.Under identical crystallization conditions, the unsupplemented protein predominantly formed microcrystals of approximately 50 μm, whereas the Zn 2+ -supplemented protein formed larger crystals of approximately 300-500 μm.These findings associate Zn 2+ supplementation with increased protein recovery and larger crystal formation, highlighting the importance of considering protein-specific cofactor requirements during recombinant protein production.

Drug Targets and TherapeuticsVol. 5(2)
Woosuk University (KR)
Ministry of Education, Ministry of Education, India
Zero hunger
Openalex Percentile: Top 13%
Trace Elements in Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Association of Zinc Supplementation with Recombinant Protein Recovery and Crystallization — Hyo Jung Kim · Drug Targets and Therapeutics (2026) | TGRS Research Map | TGRS